PRESENTATION TITLE

"Toward Ending Cancer As We Know It: A Tripartite Strategy of the American Cancer Society"

PRESENTER(S)

Karen E. Knudsen, MBA, PhD, Chief Executive Officer, American Cancer Society, Inc., American Cancer Society Cancer Action Network

VIEWING LOCATIONS
Zoom Registration Link

LEARNING OBJECTIVES

• Discuss how ACS integrates discovery, advocacy, and direct patient support to measurably improve lives.
• Convey mechanisms for integrating cancer research and cancer program growth strategies.
• Demonstrate connectivity between the non-profit sector, cancer centers, and health systems in collaborating to address cancer problems.

PRESENTERS BIO

Karen E. Knudsen, MBA, PhD, is the CEO of the American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN). As a well-respected cancer leader, researcher, and advocate, Dr. Knudsen guides the organization in the goal of improving the lives of cancer patients and their families. She has a strong commitment to ensuring that all people can benefit from the impact of our work.

Prior to joining ACS, Dr. Knudsen served as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health, one of only 71 National Cancer Institute-designated cancer centers recognized for their research and impact on cancer outcomes. As a National Cancer Institute-funded researcher, Dr. Knudsen understands the critical role government plays in saving lives from cancer. She also served as president for the Association of American Cancer Institutes (AACI), which is an important voice in advocating for funding for cancer research and access to care, including patient access to research innovations.

Dr. Knudsen currently holds leadership roles with some of the most important cancer entities in the nation. She serves on the board of advisors for the National Cancer Institute and on 12 external advisory boards for NCI-designated cancer centers. She is an active member of several committees with the American Society for Clinical Oncology (ASCO), in addition to serving on other academic and for-profit advisory boards. She previously served on the board of directors of the American Association for Cancer Research (AACR).

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.